Conversion therapy for gastric cancer: who can make conversion as successful as Goromaru? Masanori Terashima Editorial 07 April 2016 Pages: 685 - 686
MET-targeted therapy for gastric cancer: the importance of a biomarker-based strategy Hisato KawakamiIsamu Okamoto Review Article 21 December 2015 Pages: 687 - 695
The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis Emil ter VeerNadia Haj MohammadHanneke W. M. van Laarhoven Review Article Open access 11 January 2016 Pages: 696 - 712
Outcome of gastric cancer in the elderly: a population-based evaluation of the Munich Cancer Registry Anne Schlesinger-RaabAndré L. MihaljevicJutta Engel Original Article 11 August 2015 Pages: 713 - 722
Modest overall survival improvements from 1998 to 2009 in metastatic gastric cancer patients: a population-based SEER analysis Sabrina M. EbingerRené WarschkowMarc Schiesser Original Article 21 September 2015 Pages: 723 - 734
Impact of being underweight on the long-term outcomes of patients with gastric cancer Kazuhiro MigitaTomoyoshi TakayamaYoshiyuki Nakajima Original Article 23 August 2015 Pages: 735 - 743
Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer Hiroki ImaokaYuji ToiyamaMasato Kusunoki Original Article 02 August 2015 Pages: 744 - 753
CD97 promotion of gastric carcinoma lymphatic metastasis is exosome dependent Daren LiuChao LiLi Chen Original Article Open access 02 August 2015 Pages: 754 - 766
Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas Bo Gun JangByung Lan LeeWoo Ho Kim Original Article 19 September 2015 Pages: 767 - 777
MET overexpression and amplification define a distinct molecular subgroup for targeted therapies in gastric cancer Yang YangNandie WuJia Wei Original Article 24 September 2015 Pages: 778 - 788
Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients Bolag AltanTakehiko YokoboriHiroyuki Kuwano Original Article 15 October 2015 Pages: 789 - 797
Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients? Hee Jin KimNayoung KimDong Ho Lee Original Article 07 October 2015 Pages: 798 - 807
Pepsinogen-II 100 bp ins/del gene polymorphism and its elevated circulating levels are associated with gastric cancer, particularly with Helicobacter pylori infection and intestinal metaplasia Sushil KumarNiraj KumariUday C. Ghoshal Original Article 20 October 2015 Pages: 808 - 816
Antitumor effect of antiplatelet agents in gastric cancer cells: an in vivo and in vitro study Jota MikamiYukinori KurokawaYuichiro Doki Original Article 20 October 2015 Pages: 817 - 826
BAK is a predictive and prognostic biomarker for the therapeutic effect of docetaxel treatment in patients with advanced gastric cancer Tomohiro KuboYutaka KawanoJunji Kato Original Article 20 October 2015 Pages: 827 - 838
Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101) Satoshi MatsusakaAtsushi NashimotoKazuhiro Yoshida Original Article Open access 12 August 2015 Pages: 839 - 851
Epstein-Barr virus infection serves as an independent predictor of survival in patients with lymphoepithelioma-like gastric carcinoma Byung-Hoon MinChung Hyun TaeKyoung-Mee Kim Original Article 12 August 2015 Pages: 852 - 859
Lymph node metastasis risk according to the depth of invasion in early gastric cancers confined to the mucosal layer Young-Il KimJun Ho LeeIl Ju Choi Original Article 25 August 2015 Pages: 860 - 868
Is the recent WHO histological classification for gastric cancer helpful for application to endoscopic resection? Yong Hoon KimJie-Hyun KimSeung Ho Choi Original Article 01 September 2015 Pages: 869 - 875
Development of an S-1 dosage formula based on renal function by a prospective pharmacokinetic study Eisuke BookaChiyo K. ImamuraYuko Kitagawa Original Article Open access 25 August 2015 Pages: 876 - 886
Retrospective assessment of patterns of recurrence relative to radiotherapy volumes for adjuvant conformal chemoradiotherapy in gastric cancer Tatiana ConradSteve MacLellanJolie Ringash Original Article 11 September 2015 Pages: 887 - 893
Excessive watering eyes in gastric cancer patients receiving S-1 chemotherapy Hiroyuki TabuseHiroya KashiwagiHirofumi Yasui Original Article 11 September 2015 Pages: 894 - 901
Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407) Tomohiro NishinaNarikazu BokuThe Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group Original Article 19 September 2015 Pages: 902 - 910
Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication: results of a large-scale, multicenter cohort study in Japan Genki MoriTakeshi NakajimaIchiro Oda Original Article 29 September 2015 Pages: 911 - 918
Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer Hideaki BandoYasuhide YamadaIchinosuke Hyodo Original Article 16 October 2015 Pages: 919 - 926
Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer Kohei ShitaraKei MuroAtsushi Ohtsu Original Article 28 October 2015 Pages: 927 - 938
Comparison of laparoscopic versus open gastrectomy for advanced gastric cancer: an updated meta-analysis Yingjun QuanAo HuangZhijun Min Original Article 28 July 2015 Pages: 939 - 950
Liver-directed treatments for liver metastasis from gastric adenocarcinoma: comparison between liver resection and radiofrequency ablation Ali GunerTaeil SonWoo Jin Hyung Original Article 01 August 2015 Pages: 951 - 960
A phase II study of an enhanced recovery after surgery protocol in gastric cancer surgery Norihiko SugisawaMasanori TokunagaMasanori Terashima Original Article 11 August 2015 Pages: 961 - 967
Surgical treatment of liver metastasis of gastric cancer: a retrospective multicenter cohort study (KSCC1302) Eiji OkiShoji TokunagaKyushu Study Group of Clinical Cancer Original Article 11 August 2015 Pages: 968 - 976
Quality of life and nutritional consequences after aboral pouch reconstruction following total gastrectomy for gastric cancer: randomized controlled trial CCG1101 Yuichi ItoTakaki YoshikawaYasuhiro Kodera Original Article 14 August 2015 Pages: 977 - 985
Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy Yasunari FukudaKazuyoshi YamamotoToshimasa Tsujinaka Original Article 25 September 2015 Pages: 986 - 993
To Roux or not to Roux: a comparison between Roux-en-Y and Billroth II reconstruction following partial gastrectomy for gastric cancer Thuy B. TranDavid J. WorhunskyGeorge A. Poultsides Original Article 23 September 2015 Pages: 994 - 1001
Unplanned admission after gastrectomy as a consequence of fast-track surgery: a comparative risk analysis Michitaka HondaNaoki HikiToshiharu Yamaguchi Original Article 07 October 2015 Pages: 1002 - 1007
Impact of preoperative hand grip strength on morbidity following gastric cancer surgery Tsutomu SatoToru AoyamaTakaki Yoshikawa Original Article 14 October 2015 Pages: 1008 - 1015
Atrophic gastritis and enlarged gastric folds diagnosed by double-contrast upper gastrointestinal barium X-ray radiography are useful to predict future gastric cancer development based on the 3-year prospective observation Nobutake YamamichiChigaya HiranoKazuhiko Koike Short Communication 20 October 2015 Pages: 1016 - 1022
Role of age in association between gastric cancer and Helicobacter pylori eradication in cases with intestinal metaplasia and dysplasia Ali Kabir Letter to the Editor 17 April 2015 Pages: 1023 - 1023
The adjacent to tumor sample trap Paulo Pimentel de AssumpçãoSidney Emanuel Batista dos SantosRommel Mario Rodríguez Burbano Letter to the Editor 10 September 2015 Pages: 1024 - 1025
Erratum to: Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101) Satoshi MatsusakaAtsushi NashimotoKazuhiro Yoshida Erratum 30 November 2015 Pages: 1026 - 1026